Hepatopulmonary syndrome and portopulmonary hypertension;Sindrome epato-polmonare e ipertensione porto-polmonare. Inquadramento nosologico e considerazioni eziopatogenetiche

Recenti Progressi in Medicina

Volumn 92, Issue 2, 2001, Pages 158-163

  Milani, Alessandro ^a   Basso, Maria ^a   Fiorini, Alessia ^a   Pardeo, Manuela ^a   Romano, Caterina ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cirrhosis; Hepatopulmonary syndrome; Hypoxemia; Portal hypertension

Indexed keywords

HEPATOPULMONARY SYNDROME; HUMAN; PORTAL HYPERTENSION; PULMONARY HYPERTENSION; REVIEW;

HEPATOPULMONARY SYNDROME; HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY;

EID: 0035260895     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Fluckiger M. Vorkommen von trommelschagel formigen Fingerend-phalangen ohne chronische Veranderungen an der Lungen oder am Herzen. Wien Med Wochenschr 1884; 34: 1457.
2. Kennedy TC, Knudson RJ. Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis. Chest 1977; 72: 305-9.
3. Krowka MJ, Cortese DA. Hepatopulmonary syndrome: current concepts in diagnostic and therapeutic considerations. Chest 1994; 105: 1528-37.
4. Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med 1995; 122: 521-9.
5. Mandell MS, Groves BM. Pulmonary hypertension in chronic liver disease. Clin Chest Med 1996; 17: 17-34.
6. Krowka MJ. Hepatopulmonary syndrome versus portopulmonary hypertension: distinctions and dilemmas. Hepatology 1997; 25: 1282-4.
7. Hervé P, Lebrec D, Brenot F, Simonneau G, Humbert M, Sitbon O, Duroux P. Pulmonary vascular disorders in portal hypertension. Eur Respir J 1998; 11: 1153-66.
8. Krowka MJ, Dickson ER, Cortese DA. Hepatopulmonary syndrome: clinical observations and lack of therapeutic response to somatostatin analogue. Chest 1993; 104: 515-21.
9. Babbs C, Warnes TW, Haboubi NY. Non-cirrhotic portal hypertension with hypoxaemia. Gut 1998; 29: 129-31.
10. Crary GS, Burke BA, Alford BA, du Cret RP. Pulmonary arteriovenous shunting in a child with cirrhosis of the liver. Am J Dis Child 1989; 143: 749-51.
11. Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology 1991; 100: 520-8.
12. Furukawa T, Kara N, Yasumoto K, Inokuchi K. Arterial hypoxemia in patients with hepatic cirrhosis. Am J Med Sci 1984; 287: 10-3.
13. Vachiery F, Moreau R, Hadengue A, et al. Hypoxemia in patients with cirrhosis: relationship with liver failure and hemodynamic alterations. J Hepatol 1997; 27: 492-5.
14. Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995; 109: 1283-8.
15. Mimidis KP, Karatza C, Spiropoulos KV, Toulgaridis T, Charokopos Na, Thomopoulos KC, Margaritis VG, Nikolopoulou. Prevalence of intrapulmonary vascular dilatations in normoxaemic patients with early liver cirrhosis. Scand J Gastroenterol 1998; 33: 988-92.
16. Castro M, Krowka MJ. Hepatopulmonary syndrome: a pulmonary vascular complication of liver disease. Clin Chest Med 1996; 17: 35-48.
17. Agusti AGN, Roca J, Bosch J, Rodriguez-Roisin R. The lung in patients with cirrhosis. J Hepatol 1990; 10: 251-7.
18. Robin ED, Laman D, Horn BR, Theodore J. Platypnea related to orthodeoxia caused by true vascular lung shunts. N Engl J Med 1976; 294: 941-3.
19. Heinemann HO, Emirgil C, Mijnssen JP. Hyperventilation and arterial hypoxemia in cirrhosis of the liver. Am J Med 1960; 28: 239-46.
20. Rodman T, Sobel M, Close HP. Arterial oxygen unsaturation and the ventilationperfusion defect of Laennec' s cirrhosis. N Engl J Med 1960; 263: 73-7.
21. Krowka MJ, Cortese DA. Severe hypoxemia associated with liver disease: Mayo Clinic experience and experimental use of almitrine bismesylate. Mayo Clin Proc 1987; 62: 164-73.
22. Davis HH 2d, Schwartz DJ, Lefrak SS, Susman N, Schainker BA. Alveolar-capillary oxygen disequilibrium in hepatic cirrhosis. Chest 1978; 73: 507-11.
23. Krowka MJ, Cortese DA. Hepatopulmonary syndrome: an evolving perspective in the era of liver transplantation. Hepatology 1990; 11: 138-42.
24. Agusti AGN, Roca J, Rodriguez-Roisin R. Mechanisms of gas exchange impairment in patients with liver cirrhosis. Clin Chest Med 1996; 17: 49-66.
25. Robin ED, Horn B, Goris ML, Theodore J, Kessel AV, Mazoub J, et al. Detection, quantitation and pathophysiology of lung spiders. Trans Assoc Am Physicians 1975; 88: 202-16.
26. Shub C, Tajik AJ, Seward JB, Dines DE. Detecting intrapulmonary right-to-left shunt with contrast echocardiography. Observations in a patient with diffuse pulmonary arteriovenous fistulas. Mayo Clin Proc 1976; 51: 81-4.
27. Hind CR, Wong CM. Detection of pulmonary arteriovenous fistulae in patients with cirrhosis by contrast 2D echocardiography. Gut 1981; 22: 1042-5.
28. Meltzer RS, Tickner EG, Popp RL. Why do the lungs clear ultrasonic contrast? Ultrasound Med Biol 1980; 6: 263-9.
29. Krowka MJ, Tajik AJ, Dickson ER, Wiesner RH, Cortese DA. Intrapulmonary vascular dilatation in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest 1990; 97: 1165-70.
30. Nemec JJ, Davison MB, Marwick TH, Chimowitz Ml, Stoller JK, Klein AL, et al. Detection and evaluation of intrapulmonary vascular shunt with contrast Doppler transesophageal echocardiography. J Am Soc Echocardiogr 1991; 4: 79-83.
31. Hopkins WE, Waggoner AD, Barzilai B. Frequency and significance of intrapulmonary right-to-left shunting in end- stage hepatic disease. AM J Cardiol 1992; 70: 516-9.
32. Gates GF, Orme HW, Dore EK. Cardiac shunt assessment in children with macroaggregated albumin technetium-99m. Radiology 1974; 112: 649-53.
33. Genovesi MG, Tierney DF, Taplin GW, Eisenberg H. An intravenous radionuclide method to evaluate hypoxemia caused by abnormal alveolar vessels. Limitation of conventional techniques. Am Rev Respir Dis 1976; 114: 59-65.
34. Wolfe JD, Tashkin DP, Holly FE, Brachman MB, Genovesi MG. Hypoxemia of cirrhosis: detection of abnormall small pulmonary vascular channels by a quantitative radionuclide method. Am J Med 1977; 63: 746-54.
35. Rodriguez-Roisin R, Roca J, Agusti AGN, Mastai R, Wagner PD, Bosch J. Gas exchange and pulmonary vascula reactivity in patients with liver cirrhosis. Am Rev Respir Dis 1987; 135: 1085-92.
36. Daoud FS, Reeves JP, Scaeffer JW. Failure of hypoxic vasoconstriction in patients with liver cirrhosis. J Clin Invest 1972; 51: 1076-80.
37. Naeije R, Hallemans R, Mois P, Melot C. Hypoxic pulmonary vasoconstriction in liver cirrhosis. Chest 1981; 80: 570-4.
38. Campillo B, Chabrier PE, Pelle G et al. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis. Hepatology 1995; 22: 1423-9.
39. Sogni P, Monreau R, Gadano A, Lebrec D. The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension. J Hepatol 1995; 23: 218-24.
40. Panos RJ, Backer SK. Mediators, cytokines, and growth-factors in liver-lung interactions. Clin Chest Med 1996; 17: 151-69.
41. Vallance P, Moncada S. Hyperdynamic circulation in liver cirrhosis: a role for nitric oxide? Lancet 1991; 337: 776-9.
42. Laffy G, Foschi M, Simoni A et al. Increased production of nitric oxide by neutrophils and monocytes from patiens with ascites and hyperdynamic circulation. Hepatology 1995; 22: 1666-73.
43. Silverman A, Cooper MD, Moller JH, Good RA. Syndrome of cyanosis,digital clubbing,and hepatic disease in siblings. J Pediatr 1968; 72: 70-80.
44. Shijo H, Nakayama K, Sasaki H, Ueki T, Sakaguchi S, Sakata H et al. Reversibility of pulmonary telangiectasia in liver cirrhosis evidenced by serial dynamic pulmonary perfusion imaging.Clin Nucl Med 1989; 14: 909-11.
45. Shijo H, Sasaki H, Kusuhara H, Ueki T, Okumura M. Reversibility of hepatopolmunary syndrome evidenced by serial pulmonary perfusion scan. Gastroenterol Jpn 1993; 28: 126-31.
46. Nakos G, Evrenoglou D, Vassilakis N, Lampropoulos S. Haemodynamics and gas exchange in liver cirrhosis:the effect of orally administered almitrine bismesylate. Respir Med 1993; 87: 93-8.
47. Shijo H, Sasaki H, Yuh K, Sakaguchi S, Okumura M. Effects of indomethacin on hepatogenic pulmonary angiodysplasia. Chest 1991; 99: 1027-9.
48. Agusti AGN, Roca J, Bosch J, Garcia-Pagan JC, Wagner PD, Rodriguez-Roisin R. Effects of propranolol on arterial oxygenation and oxygen transport to tissues in patients with cirrhosis. Am Rev Resp Dis 1990; 142: 306-10.
49. Cadranel JL, Milleron BJ, Cadranel JF, Fermand JP, Andrivet P, Brouet JC et al. Severe hypoxemia-associated intrapulmonary shunt in a patient with chronic liver disease: improvement after medical treatment. Am Rev Resp Dis 1992; 146: 526-7.
50. Felt RW, Kozak BE, Rosch J, Duel BP, Barker AF. Hepatogenic pulmonary angiodysplasia treated with coil spring embolization. Chest 1987; 91: 920-2.
51. Riegler JL, Lang KA, Johnson SP, Westermann JH. Transjugular intrahepatic portosystemic shunt in proves oxygenation in hepatopulmonary syndrome. Gastroenterology 1995; 109: 978-83.
52. Allgaier HP, Haag K, Ochs A, Hausentein KH, Jeserich M, Krause T et al. Hepatopulmonary syndrome: successful treatment by trarisjugular intrahepatic portosystemic shunt. J Hepatol 1995; 23: 102.
53. Corley AD, Shorschmidt B, Bass N, Sonneberg K, Gold W. Lack of efficacy of TIPS for hepatopulmonary syndrome. Gastroenterology 1997; 113: 728-31.
54. Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splancnic hemodynamics. Gastroenterology 1991; 100: 520-8.
55. Raffi O, Sleirnan C, Vachiery F, Mal H, Roue C, Hadengue A, Jebrak G et al. Refractory hypoxemy during liver cirrhosis: hepato-pulmonary syndrome or "primary" pulmonary hypertension? Am J Resp Crit Care Med 1996; 153: 1169-71
56. Hervé P, LaunayJM, Scrobohaci ML et al. Increased plasma serotonin in patients with primary pulmonary hypertension. Am J Med 1995; 99: 249-54.
57. Voelkel NF, Tuder RM, Weir EK. Patophysiology of primary pulmonary hypertension: from physiology to molecular mechanisms. In: Rubin LJ, Rich S eds. Primary pulmonary hypertension. Lung biology in health and diseases. Vol. 99. New-York: Marcel Dekker 1997; 83-129.
58. Kuo PC, Plotkin JS, Howell CD, Bartlett SP, Rubin LJ. Continuous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation 3997; 63: 604-6.